Rx Only

Ready for 24-48h Central Dispatch

In Stock

LACWEL-B SACHET Clinical Monograph & Batch COA

Certified DCGI Formulation Literature (PDF)

Download

Powder & SachetPrescription Required (Schedule Drug)

LACWEL-B SACHET

Name: LACWEL-B SACHET
Brand: Sygnus Biotech

Active Drug Composition

Lactic Acid Bacillus 150 Million

WHO-GMP Certified Batch ManufacturingDCGI Approved Formulation100% BioavailableAlu-Alu Packaging

LACWEL-B SACHET (Lactic Acid Bacillus 150 Million) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.

Dosage FormCoated / Uncoated Tablet

Packaging Presentation10 x 10 Alu-Alu / Blister Pack

B2B Distributor & Healthcare Professional Notice:This product is supplied solely through verified licensed pharmaceutical distributors, stockists, and institutional tenders. Online retail checkout for prescription formulations is legally restricted.

Clinical Pharmacology & Therapeutic Profile

Comprehensive therapeutic guidelines for medical practitioners and institutional procurement

Therapeutic Indications

Indicated for therapeutic management within specified clinical indications under qualified physician guidance.

Mechanism of Action (MOA)

The active pharmacological principles in LACWEL-B SACHET deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.

Dosage & Posology

As directed by the registered medical practitioner. Strictly adhere to full course duration.

Safety & Precautions

Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.

Storage Guidelines

Store below 25°C in a dry place. Protect from moisture and direct sunlight.

WHO-GMP Certified Purity

Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.

Alu-Alu Moisture Barrier

Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.

Exclusive District Monopoly

Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.

Technical Product Specifications

Therapeutic SegmentPowder & Sachet

Dosage FormCoated / Uncoated Tablet

Packaging Type10 x 10 Alu-Alu / Blister Pack

Regulatory ScheduleSchedule H

Minimum Order Qty100 Units

Country of OriginIndia (Sidhpur Facility)

Quality StandardWHO-GMP & ISO 9001:2015

Batch Analytical COASupplied with Trade Invoice

Active Medical Composition

LACWEL-B SACHET features Lactic Acid Bacillus 150 Million prepared to high pharmaceutical purity standards.

Therapeutic ClassificationPowder & Sachet

Regulatory ScheduleSchedule Drug (Prescription Only)

*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.

Monopoly PCD Franchise

Apply for Exclusive Marketing Rights of LACWEL-B SACHET

Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.

Distributor Inquiries

Questions Regarding LACWEL-B SACHET

What is the therapeutic indication and composition of LACWEL-B SACHET?

LACWEL-B SACHET contains Lactic Acid Bacillus 150 Million indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.

What packaging presentations are available for LACWEL-B SACHET?

LACWEL-B SACHET is supplied in tamper-evident 10 x 10 Alu-Alu / Blister Pack, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.

Is monopoly PCD franchise territory available for LACWEL-B SACHET?

Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for LACWEL-B SACHET along with promotional visual aids, product cards, and marketing support.